NDC properties for "Yuflyma Auto-Injector 40 MG/0.4 ML Starter Pack - Plaque Psoriasis (4 count)" (RxCUI 2639665)
About this data
The tables show NDC propoerties for Yuflyma Auto-Injector 40 MG/0.4 ML Starter Pack - Plaque Psoriasis (4 count) with the RxCUI 2639665
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Yuflyma Auto-Injector 40 MG/0.4 ML Starter Pack - Plaque Psoriasis (4 count) (RxCUI 2639665)
| BLA | BLA761219 |
|---|---|
| RxCUI | 2639665 |
| SPL_SET_ID | 526d626f-8c9f-496c-b838-00a73bb36383 |
| Prescribable Synonym | Yuflyma Auto-Injector 40 MG/0.4 ML Starter Pack - Plaque Psoriasis (4 count) |
| RXNAV_STR | Yuflyma Auto-Injector 40 MG/0.4 ML Starter Pack - Plaque Psoriasis (4 count) |
| RxNorm Name | {4 (0.4 ML adalimumab-aaty 100 MG/ML Auto-Injector [Yuflyma]) } Pack [Yuflyma Auto-Injector 40 MG/0.4 ML Starter Pack - Plaque Psoriasis] |
| RxNorm Synonym | Yuflyma Auto-Injector 40 MG/0.4 ML Starter Pack - Plaque Psoriasis (4 count) |
| Related queries | Interactions (for RxCUI 2639665) |
NDC Properties
NDC Item 72606003011
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-11 |
| NDC Item | 72606003011 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-11) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003013
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-13 |
| NDC Item | 72606003013 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-13) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003011
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-11 |
| NDC Item | 72606003011 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-11) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |
NDC Item 72606003013
| NDC 9 | 72606-030 |
|---|---|
| NDC 10 | 72606-030-13 |
| NDC Item | 72606003013 |
| Packaging | 4 SYRINGE in 1 CARTON (72606-030-13) / .4 mL in 1 SYRINGE |
| BLA | BLA761219 |
| FDA SPL set id | 759969 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-05-23 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72606-030 |